ArticleAlzheimer's & dementia (New York, N. Y.)2022

T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease.

Aladdin H Shadyab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.